NCT06628141 Enhancing Quality of Life in Cancer Patients Through Tailored Nutrition Support: a Comprehensive Approach
| NCT ID | NCT06628141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UOMi Cancer Center |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-11-14 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-11-14 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to investigate the impact of a dedicated nutritional assistance tool on patients with cancer and to measure its effects on several proposed indicators.
Eligibility Criteria
Inclusion Criteria: * Patients affected by cancer, who decided to participate to the study, signed the informed consent and whose life expectancy is higher than 1 (one) year. Exclusion Criteria: * Patients with an eating disorder of psychiatric or psychological origin, diagnosed before cancer treatment. * Any other exclusion criteria as determined by the oncologist based on the patient's ability to successfully complete the program.
Frequently Asked Questions
Who can join the NCT06628141 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06628141 currently recruiting?
Yes, NCT06628141 is actively recruiting participants. Visit ClinicalTrials.gov or contact UOMi Cancer Center to inquire about joining.
Where is the NCT06628141 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06628141 clinical trial?
NCT06628141 is sponsored by UOMi Cancer Center. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.